Zobrazeno 1 - 10
of 2 478
pro vyhledávání: ''
Autor:
Eliano Bonaccorsi-Riani, James Ferguson, Aileen Marshall, Alberto Quaglia, Will Gelson, Phaedra Tachtatzis, Steven Masson, John C. Bucuvalas, Elisavet Kodela, Alberto Sanchez-Fueyo, J.A. Leithead, Richard Taubert, Frederik Nevens, Pablo Ruiz, Sandy Feng, Dennis Eurich, Juan G. Abraldes, Kenneth J. Simpson, Abdel Douiri, Rosa Miquel, Julien Vionnet, Julia Sidorova, J.J. Lozano, Miguel Navasa, Jurate Wall, Elmar Jaeckel, Maria Elstad
Publikováno v:
Journal of hepatology, Vol. 75, no. 6, p. 1409-1419 (2021)
BACKGROUND & AIMS: Management of long-term immunosuppression following liver transplantation (LT) remains empirical. Surveillance liver biopsies in combination with transcriptional profiling could overcome this challenge by identifying recipients wit
Publikováno v:
Journal of Hepatology
Background &Aims Liver transplant (LT) recipients or other immunocompromised patients were not included in the registration trials of vaccine studies against SARS-CoV-2. Although clinical efficacy of COVID vaccines in immunocompromised patients was u
Autor:
Ashwin Rammohan, Mohamed Rela
Publikováno v:
Journal of Hepatology. 75:975-980
Summary Acceptance of liver transplantation (LT) as an established treatment modality for end-stage liver disease has led to an exponential increase in the demand for organs, resulting in an ever-increasing gap between the availability of organs and
Autor:
Vincent Mallet, Nathanael Beeker, Samir Bouam, Philippe Sogni, Stanislas Pol, Nathanaël Beeker, Hélène Fontaine, Marion Corouge, Anaïs Vallet Pichard, Clémence Hollande, Loriane Lair Mehiri
Publikováno v:
Journal of Hepatology
Background & Aims The impact of chronic liver disease on outcomes in patients with COVID-19 is uncertain. Hence, we aimed to explore this association. Methods We explored the outcomes of all adult inpatients with COVID-19 in France, in 2020. We compu
Autor:
Philippe Mathurin
Publikováno v:
Journal of Hepatology. 75:718-722
Summary In patients with severe alcoholic hepatitis who are not responding to medical therapy, it is detrimental to postpone the decision to list a patient as there are no therapeutic alternatives. Early transplantation of patients with severe alcoho
Autor:
Vatche G. Agopian, Daniela Markovic
Publikováno v:
Journal of Hepatology. 75:732-735
Autor:
Kosuke Matsumoto, Bettina E. Hansen, Hajime Takikawa, Toshiaki Nakano, Olivier Chazouillères, Atsushi Tanaka, Fabrice Carrat, Junko Hirohara, Christophe Corpechot
Publikováno v:
Journal of Hepatology
Journal of Hepatology, 2021, 75 (3), pp.565--571. ⟨10.1016/j.jhep.2021.04.010⟩
Journal of Hepatology, 2021, 75 (3), pp.565--571. ⟨10.1016/j.jhep.2021.04.010⟩
A beneficial effect of bezafibrate (BZF) on symptoms and biochemical features of primary biliary cholangitis (PBC) has been reported in patients with an incomplete response to ursodeoxycholic acid (UDCA), but long-term effects on survival remain unkn
Autor:
Pere Ginès, Jordi Colmenero, Valeria Perez-Campuzano, Elisa Pose, Abiguei Torrents, Emma Avitabile, Gonzalo Crespo, Lluís Castells, Jordi Gratacós-Ginès, Jaume Tort, Enric Reverter, José Castellote, Isabel Campos-Varela
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Background & Aims To what extent patients with alcohol-related decompensated cirrhosis can improve until recovery from decompensation remains unclear. We aimed to investigate the probability of recovery and delisting due to improvement in patients wi
Publikováno v:
Journal of Hepatology. 76:983-985
Publikováno v:
Journal of Hepatology. 76:485-487